Animal sera were screened for an alternative enzyme source of a1,3-fucosyltransferase, and the highest activity was observed in chicken serum. A partially puriˆed enzyme fraction almost devoid of coexisting glycosidases was prepared from the chicken serum, and used for the fucosylation of LacNAc compounds. The enzyme reaction was e‹cient enough to allow the one-pot preparation of designed Le x compounds such as LNFP III.
The Lewis x (Le x ) antigen exists on the surface of several normal and malignant tissues, parasites, bacteria such as H. pylori, etc. [1] [2] [3] It has also been known as a stage speciˆc embryonic antigen-1 (SSEA-1), which is temporarily elevated in compaction of mouse embryonic cells. 4) Also, mouse embryonal carcinoma cells (EC cells), which autoaggregate Ca 2+ -dependently, express high density of Le x on embryoglycan. 5) Interestingly, these phenomena were inhibited by multivalent Le x , 6, 7) indicating the Le x involvement in cell-cell interaction. Hakomori et al. proposed that these are based on homophilic interaction between sugar chains (Le x -Le x ). 8) With regard to the synthesis of Le x compounds, several methods have been reported, [9] [10] [11] however, the enzymatic synthesis using commercially available a1,3-fucosyltransferase 12) and GDP-Fuc was not always practical because both of them were expensive and laborious to prepare. Recently, GDP-Fuc has come to be supplied less expensively. In this study, animal sera were screened as a practical source for a1,3-fucosyltransferase, and its application to the synthesis of Le x compounds is discussed.
In order to develop a practical synthetic method for Le x compounds, various animal sera were screened for an alternative source of a1,3-fucosyltransferase. As shown in Fig. 1 , the highest activity was observed in chicken serum. The chicken is known to have an a1,3-fucosyltransferase gene, 13) and the serum is available in bulk. However, its direct use resulted in degradation of acceptors and of products once formed by coexisting glycosidases. Thus, LacNAcb-pNP as an acceptor during the reaction was gradually cleaved to Gal, GlcNAc, and p-nitrophenol through a conjugated reaction involving coexisting b-galactosidase and b-N-acetylhexosaminidase in animal sera (HPLC data not shown). In the case of fucosylated products (Le x b-pNP), similar degradation also occurred through a conjugated reaction involving coexisting a-L-fucosidase and other glycosidases. In addition, glycosidase activities in chicken serum were much higher than those in other animal sera, with Gal b-oNP, GlcNAcb-pNP, LacNAcb-pNP, and Fuca-pNP as substrates (data not shown). Thus, in order to prevent such degradation of acceptors and products, it was required to eliminate both activities of b-D-galactosidase and a-L-fucosidase. To eliminate these activities, the serum was fractionated into three fractions (A, B, and C) by a phenyl-Sepharose column as shown in Fig. 2 . Desired a1,3-fucosyltransferase activity was observed in all three pooled fractions, and the speciˆc activity of fractions B and C was 22-and 6-fold higher than that of original serum, while fraction A showed only half of the activity of serum Chicken serum was fractionated into three pooled fractions A, B, and C with a phenyl-Sepharose CL-4B column. Protein contents (), hydrolytic activities toward Gal b-oNP (), GlcNAcb-pNP (#), and Fuca-pNP (), and the speciˆc activity (mU W mg protein) for a1,3-fucosyltransferase of pooled fractions were measured (see Experimental). The speciˆc activity of original serum was 0.068 mU W mg. A reaction mixture containing 2 mM LNnT (10.3 mg), 4 mM GDP-Fuc (17.9 mg), 25 mM MnCl 2 , ALP (7.5 U W ml), 10 mM Fuc, 2z BSA, and concentrated fraction B (4 ml) in 7 ml of 50 mM Na cacodylate buŠer (pH 6.8) was incubated at 379 C for 10 days. The mixture was heated at 1009 C for 5 min, and the supernatant was separated with a charcoal-Celite (2:1) column (q 2.5×12 cm) based on absorbances at 210 nm () and 485 nm () (see Experimental). H COSY spectra. Le x b-pNP was identiˆed as a novel compound. Similarly, LNnT was fucosylated to aŠord LNFP III. In charcoal-Celite chromatographic separation (Fig. 3) , LNFP III was easily obtained.
1 H-and 13 C-NMR data of desired compound were identical to those of LNFP III reported previously (See Experimental and Table 1 ). 14, 15) The yields of both Le x compounds were around 20z (based on acceptor compounds added), however, they were considered to be su‹cient for a practical method. Because the enzyme fraction is not only available in enough amounts, but also unreacted acceptors, which are very valuable substances, were recovered by straightforward column chromatography and reutilized for the synthesis. With regard to fraction C, it was not su‹cient for the synthesis, because of a low speciˆc activity (6-fold lower than that of serum).
In conclusion, the use of partially puriˆed a1,3-fucosyltransferases from chicken serum would be suitable for the one-pot synthesis of Le x compounds because the a1,3-fucosyltransferases were easily and su‹ciently prepared from chicken serum. The synthetic Le x derivatives would be useful as starting substances for the synthesis of neoglycoproteins or glycolipids, which are valuable for investigating biological recognition phenomena using lectins and cells.
Experimental
Materials. GDP-Fuc (sodium salts) was the kindly gift of Yamasa Corporation. LNnT, and LacNAcb-pNP were prepared by our methods 16, 17) from LNT II, and GlcNAcb-pNP, respectively, using transgalactosylation activity of Bacillus circulans b1,4-galactosidase (LNT II was prepared from lactose and UDP-GlcNAc using b1,3-N-acetylglucosaminyltransferase activity in bovine serum by our method 18) ). Calf intestinal alkaline phosphatase (ALP) was purchased from Boehringer Mannheim Co., Ltd. Bovine serum albumin (BSA, fraction V) and sera from bovine, porcine, chicken, goat, calf, sheep, rabbit, rat, and mouse blood were purchased from Sigma-Aldrich Co.
Analytical methods. HPLC was done with a column of Mightysil RP-18 (H) GP (q 4.6×150 mm, 5 mm, Kanto Chemical Co.) with a solvent of 10z MeOH with a ‰ow rate of 1.0 ml W min at 379 C. HPAEC-PAD was done with a column of CarboPac PA1 (q 4×250 mm) in the DIONEX system with an elution by 100 mM NaOH with 1.0 ml W min at room temperature.
1 H-and 13 C-NMR spectra of each sample in D2O were recorded on a JEOL JNM-LA 500 spectrometer at 309 C. Chemical shifts were expressed in d relative to sodium 3-(tri-methylsilyl)-propionate (TPS) as an external standard.
Screening of a1,3-fucosyltransferase activity from various animal sera. Reaction mixtures containing 2 mM LacNAcb-pNP, 6 mM GDP-Fuc, 25 mM MnCl 2 , 10 mM Fuc, ALP (7.5 U), and 360 ml of serum from bovine, porcine, chicken, calf, sheep, rat, mouse, goat, or rabbit blood in 800 ml of 50 mM Na cacodylate buŠer (pH 6.8) was incubated at 379 C. The Le xb-pNP generated was measured with HPLC and peak areas were plotted (Fig. 1) .
Partial puriˆcation of a1,3-fucosyltransferase activities from chicken serum. The precipitate from chicken serum (50 ml) with 70z ammonium sulfate saturation was dissolved in 25 ml of 20 mM Tris-HCl buŠer, pH 7.4 (TB), containing 0.4 M NaCl (buŠer A), and put onto a phenyl-Sepharose CL-4B column (q 2.6×18 cm) equilibrated with buŠer A (Fig. 2) . The column was washed with 400 ml of buŠer A, and eluted with 600 ml of TB containing 10z glycerol (buŠer B) and another 600 ml of TB containing 0.5z Triton X-100 (buŠer C) (fraction size, 20 ml W tube; ‰ow rate, 1 ml W min). Protein contents were measured with a Bio-Rad Protein Assay Kit with BSA as a standard. Glycosidase activities toward Gal b-oNP, GlcNAcb-pNP, and Fuca-pNP were measured as follows; 200 ml from each test tube was incubated with 5 mM substrate in 500 ml of 50 mM Na cacodylate buŠer (pH 6.8) at 379 C. The reaction mixture was diluted 20-fold with 1 M Na2CO3, and released oand p-nitrophenols were measured at 420 nm and 405 nm, respectively. Tubes No. 2-20 (fraction A), No. 32-50 (fraction B), and No. 62-88 (fraction C) were pooled, respectively, and assayed for protein content and a1,3-fucosyltransferase activity as described in Fig. 2 . One unit of the enzyme was dened as the amount that transfers 1 mmol of L-fucose to LacNAcb-pNP at 379 C per hour. Enzyme activity of each pooled fraction was calculated as the speciˆc activity (mU W mg protein).
Preparation of Le
x compounds by partially puriˆed chicken a1,3-fucosyltransferase. Fraction B (320 ml) from the phenyl-Sepharose column (see Fig. 3 ) was concentrated to 4 ml with an ultraˆltra-tion membraneˆlter (YM30 for cutting MW of 30,000, Amicon) and was used for the synthesis of Le x compounds. Le x b-pNP was prepared as follows. The reaction mixture containing 2.8 mM LacNAcb-pNP (10 mg), 4 mM GDP-Fuc (17.9 mg), 25 mM MnCl 2 , ALP (7.5 U W ml), 10 mM Fuc, 2z BSA, and 4 ml of concentrated fraction B (partially puriˆed chicken a1,3-fucosyltransferase) in 7 ml of 50 mM sodium cacodylate buŠer (pH 6.8) was incubated at 379 C for 10 days. The reaction mixture was monitored with HPLC and heated at 1009 C for 5 min. Supernatant from the mixture was put onto a column of Toyopearl HW-40S (q 2.6×80 cm) equilibrated with 25z MeOH, and developed with the same solvent (fraction size, 7.5 ml W tube; ‰ow rate 1 ml W min). Absorbances at 210 nm ( N-acetyl group), 300 nm ( p-nitrophenol group), and 485 nm (neutral sugar content, phenol-sulfuric acid method) of each fraction were measured and fractions (No. 38-43), in which three absorbances coincided, were collected, concentrated, and lyophilized to aŠord a single transfer product Le 13 C-NMR data (in D2O) were summarized in Table 1. LNFPIII was prepared from LNnT (10.3 mg) in a similar manner to Le x b-pNP. The reaction mixture was monitored with HPAEC-PAD and treated as previously described. The supernatant from the mixture was put onto a column of charcoal-Celite (2:1) (q 2.5×12 cm) (Fig. 3) . The column was washed with 400 ml of distilled water and eluted with a linear gradient of ethanol from 0z (300 ml) to 30z (300 ml) in total volume of 600 ml (fraction size, 7 ml W tube; ‰ow rate 1 ml W min). Absorbances at 210 nm and 485 nm of each fraction were measured and fractions in which both absorbances coincided were pooled (No. 27-39 for LNFP III; No. 42-54 for LNnT). The pooled fractions were desalted through a mixed column (q 1×5 cm) of Dowex 50W-X2 (H + form) and Bio-Rad AG-3-X4A (OH " form), and lyophilized to aŠord a single transfer product LNFPIII (2 mg), in a yield of 20z based on the acceptor (LNnT) used. C-NMR data (in D2O) were summarized in Table 1 .
